Literature DB >> 11819530

Tumor growth inhibition effect of hIL-6 on colon cancer cells transfected with the target gene by retroviral vector.

Bing Xiao, Bo Jing, Ya-Li Zhang, Dian-Yuan Zhou, Wan-Dai Zhang.   

Abstract

AIM:To observe the tumor inhibitory effects by transfecting IL-6 cDNA into colon cancer cell line HT-29 with retroviral vector pZIP cDNA.
METHODS: Human IL-6 gene was reconstructed in retrovirus vector and transfected into incasing cells PA317 by lipofectamine mediated method, the clones of the cells transferred with hIL-6 were selected by G418,and targeted HT-29 cells were infected with the virus granules secreted from PA317 and also selected by G418.Test gene transcription and expression level by hybridization, ELISA and MTT assay,etc. Analyze tumor inhibitory effects according to the cell growth curve, plating forming rate and tumorigenicity in nude mice.RESULT:Successfully constructed and transfected recombinant expressing vectors pZIPIL-6 cDNA and got positive transfected cell lines. The colon cancer cell line (HT-29 IL-6) transfected with the hIL-6 gene by retroviral vector was estab-lished. The log proliferation period and the doubling time of this cell line was between 4 to 7 days and 2.5 days according to the direct cell count, the cell proliferation was obviously inhibited with MTT assay, the plating inhibitory rate was 50% by plating efficiency test. When HT-29 IL-6 cells were inoculated into the nude mice subcutaneously, carcinogenic activity of the solid tumor was found superior to the control group and the size of tumor was not significantly enlarged. Injection of combination virus fluid containing IL-6 gene into transplantation tumors could inhibit the growth and development of the tumor.
CONCLUSION: IL-6 could inhibit the growth and proliferation of colon cancer cells by retroviral vector-mediated transduction.

Entities:  

Year:  2000        PMID: 11819530      PMCID: PMC4723605          DOI: 10.3748/wjg.v6.i1.89

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  7 in total

Review 1.  Interleukin-6: an overview.

Authors:  J Van Snick
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

2.  Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells.

Authors:  A Porgador; E Tzehoval; A Katz; E Vadai; M Revel; M Feldman; L Eisenbach
Journal:  Cancer Res       Date:  1992-07-01       Impact factor: 12.701

3.  Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.

Authors:  S M Siitonen; O P Kallioniemi; J J Isola
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

4.  Transfer of the IL-6 gene into a human colorectal carcinoma cell line and consequent enhancement of tumor antigen expression.

Authors:  K Y Tsang; S V Kashmiri; C F Qi; C Nieroda; B Calvo; R De Filippi; J W Greiner; F J Primus; J Schlom
Journal:  Immunol Lett       Date:  1993-05       Impact factor: 3.685

5.  Interleukin-6 increases carcinoembryonic antigen and histocompatibility leukocyte antigen expression on the surface of human colorectal carcinoma cells.

Authors:  C D Ullmann; J Schlom; J W Greiner
Journal:  J Immunother (1991)       Date:  1992-11

Review 6.  Apoptosis. Its significance in cancer and cancer therapy.

Authors:  J F Kerr; C M Winterford; B V Harmon
Journal:  Cancer       Date:  1994-04-15       Impact factor: 6.860

7.  Antitumor activity of recombinant interleukin 6 in mice.

Authors:  J J Mulé; J K McIntosh; D M Jablons; S A Rosenberg
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

  7 in total
  7 in total

1.  Expression of vascular endothelial growth factor and its role in oncogenesis of human gastric carcinoma.

Authors:  D H Liu; X Y Zhang; D M Fan; Y X Huang; J S Zhang; W Q Huang; Y Q Zhang; Q S Huang; W Y Ma; Y B Chai; M Jin
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

2.  Variability of cell proliferation in the proximal and distal colon of normal rats and rats with dimethylhydrazine induced carcinogenesis.

Authors:  Qing-Yong Ma; Kate E Williamson; Brian J Rowlands
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

3.  Inhibitory effect of endostatin expressed by human liver carcinoma SMMC7721 on endothelial cell proliferation in vitro.

Authors:  Xuan Wang; Fu-Kun Liu; Xi Li; Jai-Sou Li; Gen-Xin Xu
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

4.  Field population-based blocking treatment of esophageal epithelia dysplasia.

Authors:  Jun Hou; Pei-Zhong Lin; Zhi-Feng Chen; Zhen-Wei Ding; Shao-Sheng Li; Fan-Shu Men; Li-Ping Guo; Yu-Tong He; Chui-Yun Qiao; Chui-Lan Guo; Jian-Ping Duan; Deng-Gui Wen
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

5.  Potent inhibition of angiogenesis and liver tumor growth by administration of an aerosol containing a transferrin-liposome-endostatin complex.

Authors:  Xi Li; Geng-Feng Fu; Yan-Rong Fan; Chan-Fu Shi; Xin-Juan Liu; Gen-Xing Xu; Jian-Jun Wang
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

6.  Transforming growth factor-beta1 in invasion and metastasis in colorectal cancer.

Authors:  Bin Xiong; Hong-Yin Yuan; Ming-Bo Hu; Feng Zhang; Zheng-Zhuan Wei; Ling-Ling Gong; Guo-Liang Yang
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

7.  Study to evaluate molecular mechanics behind synergistic chemo-preventive effects of curcumin and resveratrol during lung carcinogenesis.

Authors:  Anshoo Malhotra; Praveen Nair; Devinder Kumar Dhawan
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.